drugset / Trial / NCT03500939

Summary

The main objective of the PROOF trial is to investigate efficacy and safety of normobaric hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in a randomized controlled clinical phase IIb trial.

Timeline

Start
2019-08-01
Primary completion
2022-05-16
Completion
2022-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 100 % Inhaled

Indications